Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease
Male
Endocrinology, Diabetes and Metabolism
Coronary Artery Disease
Kaplan-Meier Estimate
Risk Assessment
03 medical and health sciences
0302 clinical medicine
Humans
Registries
Renal Insufficiency
Original Investigation
Aged
Hypolipidemic Agents
Proportional Hazards Models
Randomized Controlled Trials as Topic
Retrospective Studies
Metabolic Syndrome
Chi-Square Distribution
Age Factors
Middle Aged
Prognosis
3. Good health
Multivariate Analysis
Female
Bezafibrate
Cardiology and Cardiovascular Medicine
DOI:
10.1186/s12933-016-0466-6
Publication Date:
2016-10-28T10:16:38Z
AUTHORS (9)
ABSTRACT
Data regarding long-term association of metabolic syndrome (MetS) with adverse outcomes are conflicting. We aim to determine the independent MetS (based on its different definitions) 20 year all-cause mortality among patients stable coronary artery disease (CAD).Our study comprised 15,524 who were enrolled in Bezafibrate Infarction Prevention registry between February 1, 1990, and October 31, 1992, subsequently followed-up for through December 2014. was defined according two definitions: The International Diabetes Federation (IDF); National Cholesterol Education Program-Third Adult Treatment Panel (NCEP).According IDF criteria 2122 (14%) had MetS, whereas NCEP definition 7446 (48%) MetS. Kaplan-Meier survival analysis showed that significantly higher by both (67 vs. 61%; log rank-p < 0.001) as well 54%; criteria. Multivariate adjusted risk 17% greater [Hazard Ratio (HR) 1.17; 95% Confidence Interval (CI) 1.07-1.28] 21% (HR 1.21; CI 1.13-1.29) using definition. Subgroup demonstrated increased associated consistent most clinical subgroups excepted renal failure (p value interaction 0.05).Metabolic is independently an 20-year CAD. This when either or definitions used. Trial registration retrospective registered.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (55)
CITATIONS (43)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....